Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, B-Cell 3Sarcoma, Ewing 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Neuroblastoma 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Lymphoma 2Leukemia, Myeloid, Acute 2Teratoma 1Seminoma 1Sarcoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Osteosarcoma 1Nonseminomatous germ cell tumor 1Myelodysplastic Syndromes 1Medulloblastoma 1Lymphoma, T-Cell 1Lymphoma, Primary Effusion 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, AIDS-Related 1Leukemia 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Histiocytosis, Langerhans-Cell 1

Interventions

tremelimumab 1etoposide phosphate 1durvalumab 1Paclitaxel 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Etoposide 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Germinoma × etoposide phosphate × Clear all
NCT02375204 2025-01-13

Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors

Alliance for Clinical Trials in Oncology

Phase 3 Active not recruiting
420 enrolled

Nonseminomatous germ cell tumor, Choriocarcinoma, Neoplasms, Germ Cell and Embryonal, Teratoma, Germinoma, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡